In addition, a strong positive correlation was observed between high FAK1 expression and shorter overall survival and progression-free survival in patients with metastatic tumors [33]; however, it was not specified by the authors if IBC samples were included in the study. This evidence concerns the gene PTK2 and metastatic neoplasm.